SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 20th, 2018 • Ho Chi Sing • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 19, 2018, between CASI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a
